Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Recursion Pharmaceuticals Inc Cl A
(NQ:
RXRX
)
6.940
+0.390 (+5.95%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Recursion Pharmaceuticals Inc Cl A
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
November Recap: Top 9 Micro/Small Cap AI Stocks Up +53%, On Average
December 03, 2023
The top 9 micro- and small-cap AI stocks advanced by 53%, on average, in November.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Hewlett Packard Enterprise Posts Upbeat Earnings, Joins Foot Locker, NetApp And Other Big Stocks Moving Higher On Wednesday
November 29, 2023
U.S. stocks traded higher, with the Nasdaq Composite gaining around 50 points on Wednesday. Shares of Hewlett Packard Enterprise Company (NYSE: HPE) moved higher during Wednesday’s session following...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Recursion Pharmaceuticals Wants to 4X Its Supercomputing Power for AI With the Help of Nvidia. Here's Why It Matters.
November 26, 2023
Scaling up means having more power to bring to bear on core activities.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
2024’s Hidden Gems: 7 Small-Caps Set for Explosive Growth
November 23, 2023
Small-cap stocks outperform larger companies on an indexed basis, but finding the best among them individually isn't always easy.
Via
InvestorPlace
This Stock Could Soar by 120%, According to Wall Street
November 22, 2023
Don't rush to buy shares just yet.
Via
The Motley Fool
Recursion Pharmaceuticals: Q3 Earnings Insights
November 09, 2023
Via
Benzinga
2 Risky Stocks With Massive Potential
October 17, 2023
Neither is doing well this year.
Via
The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
November 22, 2023
The popular growth investor keeps adding to some of her favorite stocks.
Via
The Motley Fool
Cathie Wood Just Made a Big Bet on Recursion Pharmaceuticals Stock. Will It Pay Off?
November 21, 2023
Cathie Wood just gave the company a huge vote of confidence.
Via
The Motley Fool
Unlocking AI investment opportunities in healthcare
November 16, 2023
AI is revolutionizing healthcare by improving diagnosis and accelerating drug discovery. An often-overlooked sector with a wealth of AI opportunities.
Via
MarketBeat
Topics
Artificial Intelligence
ETFs
Exposures
Artificial Intelligence
Cathie Wood Continues On Roku Shares Selling Spree After Company's Q3 Revenue Jump — Ark Sells $21.1M Of Stock
November 13, 2023
Via
Benzinga
AI Alert: 3 Healthcare Stocks That Are Investing in Artificial Intelligence
November 09, 2023
We’re still in the initial stages of a massively disruptive artificial intelligence (AI) boom that's greatly impacting healthcare.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Is Recursion Pharmaceuticals Stock a Buy Now?
October 11, 2023
The company has grabbed plenty of headlines recently.
Via
The Motley Fool
2 Cathie Wood Stocks I'm Bullish On
October 05, 2023
These two next-gen biotechs could be outstanding buys for patient investors.
Via
The Motley Fool
Bayer and Recursion Focus Research Collaboration on Oncology
November 09, 2023
Digitally enabled drug discovery for oncology has the potential to accelerate the delivery of new cancer therapies to patients. Drug discovery research collaboration may initiate up to seven oncology...
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Recursion Announces Data Collaboration Deal with Tempus, Top 50 Supercomputer Ambition Powered by NVIDIA, and Updated Focus of Collaboration with Bayer to Precision Oncology
November 09, 2023
With additional patient-centric data, compute power, and an exciting new focus for its Bayer collaboration, the company is accelerating the shift of biotech to techbio
From
Recursion Pharmaceuticals, Inc.
Via
GlobeNewswire
Is Recursion Pharmaceuticals Stock a Buy?
September 30, 2023
This small-cap stock hopes to revolutionize drug discovery with the help of AI.
Via
The Motley Fool
Recursion Provides Business Updates and Reports Third Quarter 2023 Financial Results
November 09, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
3 Stocks to Buy for Their Proximity to Nvidia
November 08, 2023
Nvidia isn't the only AI stock on the market. These three companies stand to benefit from Nvidia's success while offering diversification.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Recursion to Participate in Upcoming Investor Conference
November 02, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
The 7 Best Cathie Wood Stocks to Buy Now: November Edition
November 01, 2023
Dive into the dynamic world of Cathie Wood stocks, wagering on the disruptive tech gems shaping tomorrow's investment landscape.
Via
InvestorPlace
Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session
November 03, 2023
Gainers Benson Hill, Inc. (NYSE: BHIL) shares jumped 48.1% to $0.3740.
Via
Benzinga
2 Reasons to Buy Recursion Pharmaceuticals, and 1 Reason to Sell
October 31, 2023
Pioneering businesses tend to carry big risks, but also the potential for big rewards.
Via
The Motley Fool
3 Extra-Speculative Stocks That Could Make You Very, Very Rich
October 26, 2023
Speculative stocks are a growth investor's dream—potential for untold riches, if you can find the stocks that will survive.
Via
InvestorPlace
1 Artificial Intelligence Stock to Buy Hand Over Fist in October and 1 to Avoid
October 13, 2023
One of these players could win in AI -- and in the healthcare market, in general.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
2 AI Stocks That Aren't Worth the Hype
October 04, 2023
Even if you're bullish on AI, you may want to think twice about buying shares of these two companies.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Cathie Wood's Ark Invest Sells Nearly $4M Worth Of NVIDIA Shares — Does It Herald Shift To Undervalued AI Gems?
October 02, 2023
On Monday, Cathie Wood-led Ark Invest made a notable move by selling nearly $4 million worth of NVIDIA Corp (NASDAQ:NVDA) shares. This ...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
2 Cathie Wood Stocks That Could Deliver Exponential Returns
October 02, 2023
These two cutting-edge healthcare companies could be significantly undervalued right now.
Via
The Motley Fool
AI Investing: 12 Possible Ways To Maximize Your Returns
September 23, 2023
It all comes down to playing it smart and doing your research and to help you with that we present 12 micro/small cap AI&R stocks with descriptions of their businesses and their price-to-sales ratios,...
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Immunomics Stocks: 3 Ways to Play This Massive AI-Biotech Megatrend
September 22, 2023
Ginkgo Bioworks, Recursion Pharmaceutical, and Eli Lilly are cashing in on the AI-Biotech trend of tomorrow using the big data of today.
Via
InvestorPlace
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.